Dominika Kovacs

5PUBLICATIONS
22CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 28, 2023
Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming.

Eszter Vámos, Nikoletta Kálmán, Eva Maria Sturm

|Sep 27, 2021
Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells.

Dominika Kovács, Viola Bagóné Vántus, Eszter Vámos

|Aug 27, 2021
Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.

Kitti Andreidesz, Aliz Szabo, Dominika Kovacs

|Jul 06, 2021
Tetralone derivatives are MIF tautomerase inhibitors and attenuate macrophage activation and amplify the hypothermic response in endotoxemic mice.

János Garai, Marcell Krekó, László Őrfi

|Mar 17, 2021
Modulation of Mitochondrial Quality Control Processes by BGP-15 in Oxidative Stress Scenarios: From Cell Culture to Heart Failure.

Orsolya Horvath, Katalin Ordog, Kitti Bruszt

Pageof 1

Frequent Collaborators

4 joint publications

Balazs Radnai

4 joint publications

Ferenc Gallyas

4 joint publications

Eszter Vámos

2 joint publications

Nikoletta Kalman